Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Toxicol Appl Pharmacol ; 318: 23-32, 2017 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-28126410

RESUMO

Chemotherapy is one of the major strategies for cancer treatment. Several antineoplastic drugs including vinorelbine (VRB) are commonly intravenously infused and liable to cause serious phlebitis. The therapeutic drugs for preventing this complication are limited. In this study, the mechanism of baicalein (BCN) was investigated on VRB-induced phlebitis in vivo and vascular endothelial cell injury in vitro. Treatment with BCN obviously attenuated vascular endothelial cell loss, edema, inflammatory cell infiltration and blood clots, and reduced the serum levels of TNF-α, IL-1ß, IL-6 and ICAM-1 in the rabbit model of phlebitis induced by intravenous injection of VRB compared with vehicle. Further tests in vitro demonstrated that BCN lessened VRB-induced endothelial cell apoptosis, decreased intracellular ROS levels, suppressed phosphorylation of p38 and eventually inhibited activation of NF-κB signaling pathway. And these effects could be reversed by p38 agonist P79350. These results suggested that BCN exerted the protective effects against VRB-induced endothelial disruption in the rabbit model of phlebitis via inhibition of intracellular ROS generation and inactivation of p38/NF-κB pathway, leading to the decreased production of pro-inflammatory cytokines. Thus, BCN could be used as a potential agent for the treatment of phlebitis.


Assuntos
Antineoplásicos Fitogênicos/toxicidade , Antioxidantes/uso terapêutico , Células Endoteliais/efeitos dos fármacos , Flavanonas/uso terapêutico , Flebite/tratamento farmacológico , Vimblastina/análogos & derivados , Animais , Antioxidantes/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Relação Dose-Resposta a Droga , Células Endoteliais/metabolismo , Flavanonas/farmacologia , Células Endoteliais da Veia Umbilical Humana/efeitos dos fármacos , Células Endoteliais da Veia Umbilical Humana/metabolismo , Humanos , Mediadores da Inflamação/antagonistas & inibidores , Mediadores da Inflamação/metabolismo , Masculino , Flebite/metabolismo , Coelhos , Distribuição Aleatória , Espécies Reativas de Oxigênio/antagonistas & inibidores , Espécies Reativas de Oxigênio/metabolismo , Vimblastina/toxicidade , Vinorelbina
2.
Onkologie ; 36(5): 256-9, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23689219

RESUMO

BACKGROUND: The matrix metalloproteinases (MMPs)-2, -9 and -7 are thought to be associated with tumor invasion, metastasis, and angiogenesis. However, their possible roles in early-stage lung cancer are not clear. We measured the activity of MMP-2, -7 and -9 in early-stage lung cancer tissues. MATERIAL AND METHODS: Normal lung tissues and cancer tissues were collected from 60 consecutive stage-I non-small cell lung cancer (NSCLC) patients. The activities of MMP-2 and MMP-9 were determined by gelatin zymography, and the activity of MMP-7 was determined by casein zymography. Furthermore, the ratio of the active form of MMP-2 in tumor tissue (T) compared with normal tissue (N) was determined, and the survival in the groups with different MMP-2 T:N ratio was compared. RESULTS: The activity of both MMP-2 and MMP-9 was detected in all cancer and normal tissues. Interestingly, MMP-9 activity was significantly reduced, whereas MMP-2 activity was significantly increased, in cancer tissues compared to normal tissues. The survival rate of the MMP-2 T:N ratio > 2.5 group was 57.45%, which was significantly reduced compared with that of the T:N ratio ≤ 2.5 group (86.78%). CONCLUSION: Our findings suggest that MMP-2, but not MMP-9 and MMP-7, may be implicated in early-stage tumor invasion, metastasis, and angiogenesis in NSCLC.


Assuntos
Biomarcadores Tumorais/análise , Carcinoma Pulmonar de Células não Pequenas/química , Carcinoma Pulmonar de Células não Pequenas/mortalidade , Neoplasias Pulmonares/química , Neoplasias Pulmonares/mortalidade , Metaloproteinases da Matriz/análise , Idoso , Carcinoma Pulmonar de Células não Pequenas/patologia , China/epidemiologia , Ativação Enzimática , Feminino , Humanos , Neoplasias Pulmonares/diagnóstico , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Prevalência , Reprodutibilidade dos Testes , Medição de Risco , Fatores de Risco , Sensibilidade e Especificidade , Taxa de Sobrevida
3.
J Colloid Interface Sci ; 398: 59-66, 2013 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-23489613

RESUMO

Kaolinite-supported nanoscale zero-valent iron (K-nZVI) was successfully synthesized as a multifunctional composite and used for the degradation of crystal violet (CV). The presence of kaolinite not only decreased the aggregation of zero-valent iron nanoparticles (nZVI) with maintenance of reactivity, but also facilitated reaction by increasing the local concentration of CV in the vicinity of nZVI as an adsorbent. This was confirmed by scanning electron microscopy (SEM) and batch experiments, which showed that 97.23% of CV was removed using K-nZVI, while only 78.72% and 39.22% of CV were removed using nZVI and kaolinite after 30 min, respectively. Different factors impacting on degradation of CV were investigated as well. On the basis of these results, a removal mechanism was proposed including: (i) prompt adsorption of CV to the K-nZVI phase, and (ii) reduction of CV by Fe(0) on K-nZVI. Furthermore, different adsorption and reduction kinetics were employed to examine the removal process of CV, where a better fit with the pseudo-second-order model for adsorption and pseudo-first-order model for reduction process was observed, and reduction was the rate limiting step. In addition, isotherm and thermodynamic parameters were evaluated for a specific study of the important adsorption step. Finally, the application of K-nZVI to treat wastewater showed the removal efficiency higher than 99.9%.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA